EXTHERO

EXTHERO Canadian Trademark Information

Pharmaceutical preparations for the prevention and treatment of cardiovascular disease, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, mood disorders, bipolar disorders, seizure disorders, and smoking habits or addictions, neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy, multiple sclerosis, genitourinary diseases and disorders, namely urological diseases, urological disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases, premature ejaculation, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries, diabetes, hypertension, erectile dysfunction, sexual dysfunction, metabolic diseases and disorders, namely, insulin resistance, metabolic syndrome, hyperlipidemia, amyloidosis and dia...
Classification Information
Class Code: 005 - Pharmaceutical Products
Description: Pharmaceuticals and herbicides
Matter History Events
Status Date Record Status Description
2015-10-08 Interruption of proceeding - Abandoned - Subsection 40(3)
2015-03-03 National prosecution history entry - Extension of Time
2014-09-19 National prosecution history entry - Extension of Time
2014-03-13 National prosecution history entry - Extension of Time
2013-09-16 National prosecution history entry - Extension of Time
2013-03-25 National prosecution history entry - Extension of Time
2012-04-30 National prosecution history entry - Rep for Service Changed
2012-04-30 National prosecution history entry - Agent Changed
2011-02-11 National prosecution history entry - Allowed
2011-02-11 National prosecution history entry - Allowance Notice Sent
2010-10-27 Application published - Advertised
2010-10-22 National prosecution history entry - Extracted for Advertisement
2010-10-21 Application accepted - Approved
2010-08-31 National prosecution history entry - Approval Notice Sent
2010-07-16 National prosecution history entry - Examiner's First Report
2010-07-05 National prosecution history entry - Search Recorded
2010-03-29 Filing date accorded - Formalized
2010-03-26 National prosecution history entry - Created
2010-03-25 Application filed - Filed
Word Mark: EXTHERO
Current Status:
Interruption of proceeding
DEAD Mark!
10/8/2015
Application Number: 1474615
Filing Date: Thursday, March 25, 2010
Filing Place: Canada
Registration Date: Not Available
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Word
Use In Commerce: No
Publication Registration: Wednesday, October 27, 2010
Opposition: 10/27/2010 - 10/27/2010
Last Applicant/Owner: *********
**********
***** ****
Correspondent: Not provided
Goods and Services Information
Description:
(1) - Pharmaceutical preparations for the prevention and treatment of cardiovascular disease, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, mood disorders, bipolar disorders, seizure disorders, and smoking habits or addictions, neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy, multiple sclerosis, genitourinary diseases and disorders, namely urological diseases, urological disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases, premature ejaculation, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries, diabetes, hypertension, erectile dysfunction, sexual dysfunction, metabolic diseases and disorders, namely, insulin resistance, metabolic syndrome, hyperlipidemia, amyloidosis and diabetes mellitus, metabolic myophathies, mucolipidoses, gangliosidoses, acidosis and alkadosis, dislipidemy, sodium metabolism disorders, calcium metabolism disorders, potassium metabolism disorders, magnesium metabolism disorders, phosphate metabolism disorders, acid-base metabolism disorders, and lysosomal storage diseases, hemolytic diseases and disorders, cancer, pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain, post-herpetic neuralgia, chronic pain, inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, the respiratory system, infectious diseases, namely respiratory infections, eye infections, immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, viral diseases and disorders, namely herpes, hepatitis, stroke, psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia, depression, substance abuse disorders, namely alcoholism and drug addiction, carpal tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, multiple sclerosis, prostate disorders, pulmonary disorders, premature ejaculation, macular degeneration, thrombosis and thromboembolism, vaccines for human use; pharmaceutical preparations for use in oncology, dermatology, namely dermatitis, skin pigmentation diseases, ophthalmology, ocular disorders, gastroenterology; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; smoking cessation preparations; tissue and skin repair preparations; acne medication; allergy medication; antacids; anthelmintics; antiarrhythmics; antibiotics; anticoagulants; anticonvulsants; antidepressants; antiemetics; antiflatulants; antihistamines; antihypertensives; anti-infectives; anti-inflammatories; antiparasitics; antibacterials; antifungals; antivirals; burn relief medication; calcium channel blockers; central nervous system depressants; central nervous system stimulants; cough treatment medication; diarrhea medication; gastrointestinal medication; glaucoma agents; hydrocortisone; hypnotic agents; sedatives; and ophthalmic preparations.
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.
What You Can Do:

This mark may be available for re-registration. You can apply for it through Trademarkia at a low cost of $449!

Trademarkia.com will perform a final search in order to verify that this mark is available for Canada Trademark re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!
As seen on